BBIO – Acoramidis AG10 TTR – ESC-HF 2025 – All-cause Mortality, Cardiovascular Hospitalization and NT-proBNP in Variant ATTR-CM from ATTRibute-CM

BridgeBio Pharma Inc. published this content on May 18, 2025, and is solely responsible for the information contained herein. Distributed via Public Technologies (PUBT), unedited and unaltered, on June 04, 2025 at 17:40 UTC. If you believe the information included in the content is inaccurate or outdated and requires editing or removal, please contact us at support@pubt.io